Latest AI and machine learning research in dementia for healthcare professionals.
Introduction: The eligibility of anti-amyloid disease-modifying therapies (DMTs) and their integrati...
Background: Cognitive decline and dementia represent major public health challenges in aging populat...
Background: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by cognitive decl...
Reliable Alzheimer's disease (AD) diagnosis increasingly relies on multimodal assessments combining ...
Generative AI framework-based modeling and prediction of longitudinal human brain images offer an ef...
Alzheimer's disease is a progressive neurodegenerative disorder in which mild cognitive impairment (...
Disease progression modeling provides a robust framework to identify long-term disease trajectories ...
Deep learning models for medical image analysis often act as black boxes, seldom aligning with clini...
Abstract Background Neurodegenerative diseases, including Alzheimer's disease (AD), exhibit substant...
Alzheimer's disease (AD) and Lewy body dementia (LBD) present overlapping clinical features yet requ...
Alzheimer's disease (AD) is a progressive neurodegenerative condition necessitating early and precis...
TAR DNA-binding protein 43 (TDP-43) aggregation is a hallmark of several neurodegenerative diseases,...
Calcium dynamics controls learning and memory. Changes in calcium-induced calcium release (CICR), wh...
INTRODUCTION: Treatment response in Alzheimer's disease (AD) varies substantially across patients, y...
Body mass index (BMI), type 2 diabetes (T2D) and associated cardiometabolic features modify Alzheime...
INTRODUCTION: Cognitively unimpaired (CU) adults show substantial variation in their risk of develop...
Background: Natural language processing (NLP) systems integrated into clinical workflows show promis...
Background: Subtle changes in spontaneous language production are among the earliest indicators of c...
Early Alzheimer's disease often evades timely detection because typical diagnostics are based on sym...
Introduction: Plasma phosphorylated tau-217 is widely used as a plasma-based biomarker for Alzheimer...
-Synuclein (-syn) strains can serve as discriminators between Parkinson's disease (PD) and related -...